Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain Metastases
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Lapatinib ditosylate may stop the growth of tumor cells by blocking some of the
enzymes needed for cell growth and by blocking blood flow to the tumor. Drugs used in
chemotherapy, such as capecitabine, work in different ways to stop the growth of tumor cells,
either by killing the cells or by stopping them from dividing. Giving lapatinib ditosylate
together with capecitabine may kill more tumor cells.
PURPOSE: This phase II trial is studying how well giving lapatinib ditosylate together with
capecitabine works in treating patients with stage IV breast cancer and brain metastases.